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Background/aim: This study was designed to evaluate the effect of antimicrobial photodynamic treatment (APDT) in a biofilm model
using combinations of various dyes (rose bengal, riboflavin, and methylene blue) as photosensitizers and light sources (LED and UVA)
against staphylococcal and candidal biofilms.
Materials and methods: Sterile microtiter plates were used for the development and quantification of the biofilms. APDT was
carried out using combinations of the light sources and dyes. The percentage of the growth inhibition was then calculated using a
spectrophotometer. The broth media in the wells were aspirated, wells were stained with crystal violet, and optical density values were
measured spectrophotometrically. SEM analysis of the impact of APDT on bacterial and fungal biofilms was also performed.
Results: The experiments showed that the most efficacious combination was red LED + methylene blue against both staphylococcal and
candidal biofilms. A marked inhibition (45.4%) was detected on both C. albicans and C. parapsilosis biofilms. Red LED + methylene blue
was also effective on S. aureus and S. epidermidis biofilms. SEM images suggested that the number of adherent cells and biofilm mass
were markedly reduced after APDT treatment.
Conclusion: Although the results of this study indicated the in vitro efficacy of APDT, it might also be a promising technique for the
control of biofilm growth within intravenous catheters.
Key words: Antimicrobial photodynamic therapy, biofilm, Candida, Staphylococcus

1. Introduction
Antimicrobial photodynamic treatment (APDT) has
emerged in recent years as an adjunctive to the conventional
antimicrobial therapeutic modality for the treatment
of different types of bacterial and fungal infections.
Photodynamic antimicrobial therapy represents an
alternative antibacterial, antifungal, and antiviral treatment
against drug-resistant organisms (1). It is a novel approach
based on the interaction of a nontoxic photosensitizer and
a harmless low-energy light source. The combination of
these two factors in the presence of oxygen results in the
creation of reactive oxygen species and triggers a cascade
of biological events that leads to apoptosis and the death
of microorganisms. This antimicrobial approach may
help to destroy the microbial populations in biofilms. The
biofilm matrix surrounding microbial cells makes them
tolerant to harsh conditions and resistant to antimicrobial
treatments. Hence, it is critically important to design or

screen antibiofilm practices that can effectively minimize
and eradicate biofilm-related catheter infections (2).
Staphylococcus spp., Enterococcus spp., gram-negative
bacilli, and Candida spp. are the most commonly
encountered
microorganisms
in
catheter-related
bloodstream infections (CRBSIs). Poor clinical response to
antimicrobial therapy is related to the biofilm production
among these microorganisms. Clinical practice guidelines
recommend the removal of the catheter or antimicrobial
lock therapy in certain conditions (3). APDT is a promising
salvage therapy for CRBSIs because it can help to prevent
biofilm formation and rapidly reduce the bacterial and
candidal load from the biofilms developed on the surface
of the intravenous catheters (1,3–5).
In this study, the in vitro effectiveness of photodynamic
therapy in the reduction of biofilms grown in microplate
wells and on glass slide surfaces was evaluated. A
biofilm model was constructed to assess the effect of
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photodynamic therapy using rose bengal (RB), riboflavin
(RBF), and methylene blue (MB) as the photosensitizer
agents combined with UVA and LED light sources against
staphylococcal and candidal biofilms.
2. Materials and methods
2.1. Bacterial and fungal strains
Staphylococcus aureus ATCC 35556, Staphylococcus
epidermidis ATCC 35984, Candida albicans ATCC 90028,
and Candida parapsilosis ATCC 96142 were used in this
study as reference strains for biofilm production. Fungal
strains were cultivated on Sabouraud dextrose agar plates
and bacterial strains were grown on Mueller Hinton
agar plates for 24 h at 35 °C under aerobic conditions.
Overnight cultures of each strain diluted in sterile saline
were used to prepare the test suspensions. The turbidity
of each suspension was adjusted to the equivalent of 3
× 106 CFU/mL for Candida spp. and 3 × 108 CFU/mL
for Staphylococcus spp. using the McFarland turbidity
standards (2,4,5).
2.2. Biofilm formation
Biofilm formation was evaluated and quantified using a
96-well polystyrene microtiter plate assay plus scanning
electron microscopy (SEM). Biofilms were grown in the
wells of sterile microplates and on the surface of 1 cm × 1
cm glass slides. Flat-bottom microplates (Corning) were
inoculated with aliquots of 20 µL of bacteria and yeast cell
suspensions and 180 µL of Mueller Hinton broth (MHB).
The microplates were incubated at 37 °C for 72 h in an
orbital shaker at 150 rpm to ensure biofilm formation.
In addition, aliquots of 1 mL of bacterial and fungal
suspensions were inoculated into 6-well culture plates
(Thermo Fisher Scientific) containing 1 mL of MHB for
SEM analysis. Glass slides were then placed into each of
these wells. After incubation for 72 h, these glass slides
were used for SEM analysis (2,4,5).
2.3. Light sources and photosensitizers
The light sources used in the treatment of biofilms were
one UVA lamp, with a wavelength of 370 nm, and two
LED lamps, one emitting light in the red spectrum at
660 nm and the other in the green spectrum at 518 nm.
Photosensitizers, obtained from Sigma-Aldrich (St. Louis,
MO, USA), were watery solutions of RBF (1 g/1 L, 0.1%,
in distilled water), used in conjunction with UVA; MB (25
µg/mL), used in conjunction with red LED; and RB (1 g/ 1
L, 0.1%, in distilled water), used in conjunction with blue
LED (2,6).
2.4. Photodynamic treatment of biofilms and antibiofilm
assay
After 72 h of incubation with resulting biofilm formation,
10 µL of RBF (0.1%), 10 µL of MB (25 µg/mL), and 10 µL
of RB (0.1%) suspensions were added to the wells of the
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microplates. Biofilm control plates were left without an
antimicrobial drug for the formation of biofilms. In order
to prevent microbial growth and biofilm formation in
negative controls, amphotericin B was added to the wells of
the microplates containing Candida spp. and teicoplanin
was added to the wells of the microplates containing
Staphylococcus spp. Microplates were then exposed to
the corresponding light sources for 5 min. Intensity of
the light spot was measured with a power meter (PM200,
Thorlabs GmbH, Dachau, Germany). The applied PDT
was 0.77 mW and energy fluency was set to 233 mJ/cm2
when irradiated for 300 s (mW (J/s) × s = mJ).
Biofilm formation on the surface of microplates and
the antibiofilm effect of APDT were evaluated using a
quantitative crystal violet assay as described previously
(7). Briefly, the culture broth media in the wells of the
microplates was aspirated gently, and wells were washed
twice with distilled water. After the media and microbial
cells were discarded, the remaining biofilm was stained
with crystal violet for 1 min. Biofilm formation was then
quantified by measuring the optical density values in
each well using a spectrometer at 630 nm. The biofilm
inhibition index was calculated for each well using the
following formula: Biofilm inhibition index: (untreated
control biofilm OD – treated biofilm OD) / untreated
control biofilm OD × 100. The effect of APDT on the
treated biofilms were determined in comparison with the
untreated biofilms.
2.5. Photodynamic inactivation of planktonic cells
To observe the impact of PDT on biofilm formation by
bacteria and fungi, survival of the microbial cells after the
treatment was also analyzed in addition to the quantification
of biofilm by crystal violet assay. The viability of bacteria
and fungi was analyzed by counting the numbers of CFU/
mL after plating on appropriate culture media. Briefly,
108 CFU/mL suspensions of bacteria (S. aureus and S.
epidermidis) and 106 CFU/mL suspensions of fungi (C.
albicans and C. parapsilosis) in phosphate-buffered saline
were incubated with each of the photoactivators in the
dark for 15 min and were then exposed to different light
sources. After 300 s of treatment, aliquots of 10 µL of cell
suspensions were inoculated onto SDA and MHA plates
and incubated at 37 °C for 24 h. Following 24 h of growth,
colonies were counted, expressed in CFU/mL, and the
effects of APDT on the count reduction (log CFU/mL) of
bacterial and fungal cells were determined (2).
2.6. Scanning electron microscopy
SEM analysis was used in order to visualize the effect of
APDT on grown bacterial and fungal biofilms. Briefly,
biofilms were grown on 1 cm × 1 cm sterile glass slides
as described above in 6-well culture plates. After the
photodynamic treatment, slides were removed, initially
fixed using 2.5% glutaraldehyde + 2% formaldehyde in
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phosphate buffer for 2 h at 4 °C, and were then rinsed in
distilled water. A series of ethanol washes (20%, 40%, 60%,
80%, and 100%) for 30 s was used for dehydration of the
glass slides. Glass slides were then dried in air for 24 h and
examined by SEM (8).
3. Results
3.1. Estimation of antibiofilm treatment
Biofilm formation and antibiofilm activity were assessed
using crystal violet staining assay. In comparison with
the biofilm controls, it was observed that red LED + MB
combination reduced biofilm formation by all of the
Candida and Staphylococcus strains, as shown in Table 1.
In contrast, RBF + UV treatment showed only minimal
effect on the test strains, whereas the effect of green LED +
RB was found to be variable among strains.
Biofilm inhibition index values were calculated for
each well. Table 2 depicts the biofilm inhibition indexes. As
shown in Table 2, the group in which red LED + MB was
used showed a higher biofilm inhibition index in all of the
microorganisms. The red LED + MB combination reduced
biofilm formation by 45.4% both in C. albicans and C.
parapsilosis. The groups to which RBF + UV was applied
showed the lowest biofilm inhibition when compared
with other groups. RBF + UV showed no effect on biofilm

formation in C. parapsilosis and only minimally reduced
the formation of biofilm in S. aureus and S. epidermidis,
and by 24.5% in C. albicans. On the other hand, the biofilm
inhibition effect of the green LED + RB combination was
found to be variable among strains. An inhibitory effect
of green LED + RB was observed for S. aureus and C.
albicans, while no effect was found in other groups. Of the
light sources and photosensitizer combinations, the red
LED + MB combination showed the most promising effect
on all microorganisms.
In the negative control groups in which amphotericin
B or teicoplanin was used, unexpected results were
observed, showing biofilm formation to some extent
(Table 1). This unexpected result demonstrated that
although amphotericin B and teicoplanin were used in
order to observe the inhibitory effect of these drugs on
biofilm formation, biofilms still developed to some extent
in both the Candida and Staphylococcus strains, indicating
that they could not completely prevent biofilm growth.
3.2. Planktonic cell assay results
The antimicrobial activity of APDT on planktonic cells
was evaluated by counting colony numbers and estimating
log reductions. As shown in Figure 1, red LED + MB and
RBF + UV combinations markedly reduced the number of
surviving cells in both Candida and Staphylococcus strains.

Table 1. Mean optical density values obtained by crystal violet assay after APDT.
Mean OD values of biofilm formed wells

Biofilm controls

C. albicans

C. parapsilosis

S. aureus

S. epidermidis

0.110

0.110

0.160

0.100

Negative controls

0.140

0.120

0.100

0.080

Red LED + MB

0.060

0.060

0.040

0.040

Green LED + RB

0.085

0.158

0.238

0.037

RBF + UV

0.083

0.110

0.147

0.091

Light-emitting diode (LED), methylene blue (MB), rose bengal (RB),riboflavin (RBF).
Table 2. Biofilm inhibition index values after APDT estimated for Candida and Staphylococcus strains.
Biofilm inhibition index
C. albicans

C. parapsilosis

S. aureus

S. epidermidis

Negative controls

–27.2

–9

37.5

27.2

Red LED + MB

45.4

45.4

75

60

Green LED + RB

22.7

–43.6

–48.7

63

RBF + UV

24.5

0

8.1

9

Light-emitting diode (LED), methylene blue (MB), rose bengal (RB),riboflavin (RBF).
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Planktonic cell assay
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Figure 1. Colony numbers of Candida and Staphylococcus strains
after APDT. Riboflavin (RBF), light-emitting diode (LED),
methylene blue (MB).

In all planktonic treatment groups with red LED + MB and
UV + RBF, there were more than 3 log10 reductions in the
number of bacteria and fungi. Treatment with red LED
+ MB was the most prominent, resulting in a 4 log10 or
greater kill in Staphylococcus strains.
3.3. Analysis of biofilm structure under scanning electron
microscope
In the second part of the experiment, SEM analysis was
used to observe the impact of APDT on 72-h bacterial
and fungal biofilms. After biofilms were grown on glass
slides in 6-well culture plates as described above, the
APDT procedure was carried out. After treatment, slides
were removed and evaluated by SEM. The biofilms treated
with or without APDT are shown in Figure 2. SEM images
revealed a change in biofilm formation after treatment
with APDT. As shown in Figure 2, it was clearly observed
that the number of adherent cells on the surface of glass
slides was markedly reduced after treatment.
4. Discussion
This study focused on the investigation of the efficacy
of APDT on biofilms formed by Staphylococcus and
Candida species. Three different photosensitizers and
two different light sources with various combinations
between them were evaluated. It was found that the most
efficacious combination was red LED + MB against both
the Staphylococcus and the Candida strains used in the
experiments. A marked inhibition (45.4%) was detected
for both C. albicans and C. parapsilosis biofilms. Red LED
+ MB treatment was also very effective on S. aureus and
S. epidermidis biofilms (75% and 60%, respectively). The
efficacy of green LED + RB was found to be variable. It
revealed 22.7% inhibition on C. albicans biofilm, but had
no effect on C. parapsilosis biofilm. Green LED + RB
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did not show any inhibitory effect on S. aureus biofilm;
however, it inhibited the biofilm formed by S. epidermidis
(63%). RBF + UV treatment resulted in 24.5% inhibition
of C. albicans biofilm, while no effect was detected for C.
parapsilosis and bacterial biofilms.
The increase in the survival and resistance of
microorganisms organized in biofilms demonstrates that
alternative, safer, and effective antimicrobial strategies are
urgently needed (9). Bacterial and fungal biofilm-related
infections are difficult to eradicate since the effective
penetration of antimicrobials through the biofilm is
limited. APDT provides an opportunity to act locally,
causing selective damage to target cells (2). Studies on the
APDT approach to combat microbial biofilms have proven
that it can be effective against biofilm-producing bacteria
and fungi (especially Staphylococcus spp. and Candida
spp.) (10). It was reported that APDT mediated by MB
promoted an average reduction of 2.81 log10 CFU in S.
mutans biofilms, as well as an average reduction of 3.29
log10 CFU in S. aureus biofilms (11).
Several studies evaluated the antibacterial effect
of APDT; however, the number of studies about the
antibiofilm efficacy of APDT is comparatively low.
Published studies were mainly in the dentistry area,
addressing the effect of APDT on oral cavity bacteria.
Only three photoantimicrobial agents (MB, toluidine blue
O, and indocyanine green) have so far received clinical
approval in dentistry as an adjuvant approach (9).
Catheter-related infections provide promising
opportunities for the therapeutic approach of APDT since
the association of biofilms and CRBSIs is clearly defined
(12). The most common etiological agents of CRBSIs are
Staphylococcus spp. and Candida spp. Current guidelines
generally recommend the removal of infected catheters
due to S. aureus and Candida species because of their
higher mortality rates. On the other hand, it was reported
that, in some cases, beside antibiotic lock therapy, APDT
can provide a salvage for infected catheters (3).
Several studies demonstrated the effectiveness of
APDT on planktonic cells. Perez-Laguna et al. (13)
demonstrated that the photosensitizing agents RB and MB
effectively inactivated S. aureus by a 6 log10 reduction in
bacterial growth. The combination of RB and MB with the
antibiotics mupirocin or linezolid showed a synergistic
bactericidal effect on S. aureus in vitro. Vecchio et al. (14)
showed the in vitro effect of MB-APDT against both S.
aureus and MRSA using white light lamps and red LED
lamps. In another study, De Oliveira et al. (15) evaluated
the in vitro bactericidal effect of APDT on S. aureus
(ATCC 25923) using different concentrations (100, 50, 25,
12.5, and 6.25 µg/mL) of the phenothiazine compound
combined with LED light (λ 632 ± 2 nm) using varied
energy densities (12, 9.6, 7.2, 4.8, and 2.4 J/cm2). They
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Figure 2. Scanning electron microscope images: a, c) Candida parapsilosis biofilm before APDT; b, d) C. parapsilosis
biofilm after APDT; e) S. epidermidis biofilm before APDT; f) S. epidermidis biofilm after APDT.
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showed that a single application of APDT, using energy
density of 12 J/cm2 associated either with 12.5 or 25 µg/
mL of phenothiazine, resulted in higher in vitro inhibition
of S. aureus.
The antimicrobial effect of a variety of photosensitizers
on different pathogenic microorganisms including
Candida albicans has been demonstrated by different
authors. Some studies revealed high rates of reduction
in the metabolic activity of biofilms formed from clinical
isolates of C. albicans, C. tropicalis, and C. glabrata after
exposure to APDT. Costa et al. (16) used RB and blue light
LED for the photodynamic inactivation of planktonic
cultures and biofilms of C. albicans and observed a
reduction. They suggested that the combination of LED
and RB exerted a photodynamic effect on C. albicans
biofilm. Rossetti et al. (17) studied the effects of APDT
using toluidine blue as a photosensitizing agent on the
production of ROS, cell damage, and the ability of C.
albicans to form biofilms.
APDT seems to be a promising alternative approach to
conventional antibiotic therapy in response to the problem
of antimicrobial resistance, especially in biofilm-based
localized infections. The main advantages of APDT are
the killing of microorganisms equally regardless of their
intrinsic or acquired antibiotic resistance, no development
of microbial resistance, and minimal damage to the host

tissues (10). APDT has been widely used in various clinical
conditions, such as cancers/tumors (skin, brain, lungs,
pleura, gastrointestinal system, genitourinary system,
head and neck), ophthalmic diseases, and cardiovascular
diseases (18). APDT may help to prevent biofilm formation
in intravenous catheters and may improve antibiofilm
strategies. Certainly, the main goal is the minimization of
catheter-related nosocomial infections.
Different LED light sources for APDT have been used
in various studies. Even though there is no standardization
of the wavelengths of LED light sources against various
microorganisms, red LED with a wavelength of 620–660
nm yielded better results (6). In this study, three different
LED light sources and photosensitizers have been chosen
according to the previous studies and red LED (660 nm)
and MB together were found to be more effective against
both S. aureus (75%) and Candida spp. (45.4%).
In conclusion, the results of this study suggested that
APDT had some ability to reduce the biofilm formation.
APDT may have a role in the prevention or treatment
of catheter-related bloodstream infections in the future.
Further clinical studies are required to establish a safe and
effective light dose for different body sites. The growing
number of in vivo studies verifying future applications of
various photosensitizers is encouraging and the key is to
be brave enough to use them in clinical diseases.
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